|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/10 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/24 | (2006.01) |
| (11) | Number of the document | 4025187 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21724651.1 |
| Date of filing the European patent application | 2021-05-07 | |
| (97) | Date of publication of the European application | 2022-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-03 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/EP2021/062144 |
| Date | 2021-05-07 |
| (87) | Number | WO 2022/111858 |
| Date | 2022-06-02 |
| (30) | Number | Date | Country code |
| 202063119382 P | 2020-11-30 | US |
| (72) |
GOPAL, Srihari , US
VENKATASUBRAMANIAN, Raja , US
T'JOLLYN, Huybrecht , BE
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Dozavimo režimai, susiję su prailginto atpalaidavimo injekcinėmis paliperidono vaisto formomis |
| DOSING REGIMENS ASSOCIATED WITH EXTENDED RELEASE PALIPERIDONE INJECTABLE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 5 | 115.00 EUR |
| 2026-05-07 |